Citalopram enhances cocaine's subjective effects in rats

Paul L. Soto, Takato Hiranita, Jonathan L. Katz

Research output: Contribution to journalArticle

Abstract

Serotonin-selective reuptake inhibitors (SSRIs) have been shown to enhance the locomotor stimulatory, discriminative-stimulus, and convulsive effects of cocaine in rodents. A pharmacokinetic mechanism for the interaction is supported by increases in the brain levels of cocaine by fluoxetine treatment. Furthermore, the locomotor-stimulant effects of cocaine in rodents are enhanced by fluoxetine and fluvoxamine, SSRIs known to inhibit cocaine-metabolizing cytochrome P450 enzymes, whereas citalopram, an SSRI that does not inhibit P450 enzymes, does not enhance cocaine's locomotor-stimulant effects. Citalopram, however, attenuated the discriminative-stimulus effects of cocaine in squirrel monkeys trained to discriminate cocaine from saline, though it enhanced the discriminative-stimulus effects of a low dose of cocaine in rats trained to discriminate high and low doses of the drug. This study investigated the effects of citalopram on cocaine's discriminative-stimulus effects in rats trained more simply to discriminate cocaine from saline. Citalopram alone produced predominantly saline-appropriate responding, but when administered before cocaine, citalopram dose-dependently shifted the cocaine dose-response curve leftward. The present findings suggest that enhancement of cocaine's discriminative-stimulus effects may occur through a mechanism different from that underlying enhancement of cocaine's locomotor effects or that another action of citalopram selectively blocks locomotor enhancement.

Original languageEnglish (US)
Pages (from-to)759-762
Number of pages4
JournalBehavioural Pharmacology
Volume20
Issue number8
DOIs
StatePublished - Dec 2009

Fingerprint

Citalopram
Cocaine
Serotonin Uptake Inhibitors
Cytochrome P-450 Enzyme System
Fluoxetine
Rodentia
Fluvoxamine
Saimiri

Keywords

  • Citalopram
  • Cocaine
  • Drug discrimination
  • Rats

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Citalopram enhances cocaine's subjective effects in rats. / Soto, Paul L.; Hiranita, Takato; Katz, Jonathan L.

In: Behavioural Pharmacology, Vol. 20, No. 8, 12.2009, p. 759-762.

Research output: Contribution to journalArticle

Soto, Paul L. ; Hiranita, Takato ; Katz, Jonathan L. / Citalopram enhances cocaine's subjective effects in rats. In: Behavioural Pharmacology. 2009 ; Vol. 20, No. 8. pp. 759-762.
@article{e1bfe8ff778144869c28495cfbeb1ce6,
title = "Citalopram enhances cocaine's subjective effects in rats",
abstract = "Serotonin-selective reuptake inhibitors (SSRIs) have been shown to enhance the locomotor stimulatory, discriminative-stimulus, and convulsive effects of cocaine in rodents. A pharmacokinetic mechanism for the interaction is supported by increases in the brain levels of cocaine by fluoxetine treatment. Furthermore, the locomotor-stimulant effects of cocaine in rodents are enhanced by fluoxetine and fluvoxamine, SSRIs known to inhibit cocaine-metabolizing cytochrome P450 enzymes, whereas citalopram, an SSRI that does not inhibit P450 enzymes, does not enhance cocaine's locomotor-stimulant effects. Citalopram, however, attenuated the discriminative-stimulus effects of cocaine in squirrel monkeys trained to discriminate cocaine from saline, though it enhanced the discriminative-stimulus effects of a low dose of cocaine in rats trained to discriminate high and low doses of the drug. This study investigated the effects of citalopram on cocaine's discriminative-stimulus effects in rats trained more simply to discriminate cocaine from saline. Citalopram alone produced predominantly saline-appropriate responding, but when administered before cocaine, citalopram dose-dependently shifted the cocaine dose-response curve leftward. The present findings suggest that enhancement of cocaine's discriminative-stimulus effects may occur through a mechanism different from that underlying enhancement of cocaine's locomotor effects or that another action of citalopram selectively blocks locomotor enhancement.",
keywords = "Citalopram, Cocaine, Drug discrimination, Rats",
author = "Soto, {Paul L.} and Takato Hiranita and Katz, {Jonathan L.}",
year = "2009",
month = "12",
doi = "10.1097/FBP.0b013e328333a267",
language = "English (US)",
volume = "20",
pages = "759--762",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Citalopram enhances cocaine's subjective effects in rats

AU - Soto, Paul L.

AU - Hiranita, Takato

AU - Katz, Jonathan L.

PY - 2009/12

Y1 - 2009/12

N2 - Serotonin-selective reuptake inhibitors (SSRIs) have been shown to enhance the locomotor stimulatory, discriminative-stimulus, and convulsive effects of cocaine in rodents. A pharmacokinetic mechanism for the interaction is supported by increases in the brain levels of cocaine by fluoxetine treatment. Furthermore, the locomotor-stimulant effects of cocaine in rodents are enhanced by fluoxetine and fluvoxamine, SSRIs known to inhibit cocaine-metabolizing cytochrome P450 enzymes, whereas citalopram, an SSRI that does not inhibit P450 enzymes, does not enhance cocaine's locomotor-stimulant effects. Citalopram, however, attenuated the discriminative-stimulus effects of cocaine in squirrel monkeys trained to discriminate cocaine from saline, though it enhanced the discriminative-stimulus effects of a low dose of cocaine in rats trained to discriminate high and low doses of the drug. This study investigated the effects of citalopram on cocaine's discriminative-stimulus effects in rats trained more simply to discriminate cocaine from saline. Citalopram alone produced predominantly saline-appropriate responding, but when administered before cocaine, citalopram dose-dependently shifted the cocaine dose-response curve leftward. The present findings suggest that enhancement of cocaine's discriminative-stimulus effects may occur through a mechanism different from that underlying enhancement of cocaine's locomotor effects or that another action of citalopram selectively blocks locomotor enhancement.

AB - Serotonin-selective reuptake inhibitors (SSRIs) have been shown to enhance the locomotor stimulatory, discriminative-stimulus, and convulsive effects of cocaine in rodents. A pharmacokinetic mechanism for the interaction is supported by increases in the brain levels of cocaine by fluoxetine treatment. Furthermore, the locomotor-stimulant effects of cocaine in rodents are enhanced by fluoxetine and fluvoxamine, SSRIs known to inhibit cocaine-metabolizing cytochrome P450 enzymes, whereas citalopram, an SSRI that does not inhibit P450 enzymes, does not enhance cocaine's locomotor-stimulant effects. Citalopram, however, attenuated the discriminative-stimulus effects of cocaine in squirrel monkeys trained to discriminate cocaine from saline, though it enhanced the discriminative-stimulus effects of a low dose of cocaine in rats trained to discriminate high and low doses of the drug. This study investigated the effects of citalopram on cocaine's discriminative-stimulus effects in rats trained more simply to discriminate cocaine from saline. Citalopram alone produced predominantly saline-appropriate responding, but when administered before cocaine, citalopram dose-dependently shifted the cocaine dose-response curve leftward. The present findings suggest that enhancement of cocaine's discriminative-stimulus effects may occur through a mechanism different from that underlying enhancement of cocaine's locomotor effects or that another action of citalopram selectively blocks locomotor enhancement.

KW - Citalopram

KW - Cocaine

KW - Drug discrimination

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=73949123323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949123323&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e328333a267

DO - 10.1097/FBP.0b013e328333a267

M3 - Article

C2 - 20195220

AN - SCOPUS:73949123323

VL - 20

SP - 759

EP - 762

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 8

ER -